Skip to main page content

• HOME
• Current Issue
• Archive
• Alerts
• About ASM
• Contact us
• Tech Support
• Journals.ASM.org

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Auewarakul, P. Articles by Puthavathana, P. Search for Related Content PubMed PubMed Citation Articles by Auewarakul, P. Articles by Puthavathana, P.

 Previous Article  |  Next Article 

Journal of Virology, September 2007, p. 9950-9955, Vol. 81, No. 18
0022-538X/07/$08.00+0     doi:10.1128/JVI.00468-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

An Avian Influenza H5N1 Virus That Binds to a Human-Type Receptor

Prasert Auewarakul,^1* Ornpreya Suptawiwat,¹ Alita Kongchanagul,¹ Chak Sangma,⁶ Yasuo Suzuki,⁷ Kumnuan Ungchusak,⁴ Suda Louisirirotchanakul,¹ Hatairat Lerdsamran,¹ Phisanu Pooruk,¹ Arunee Thitithanyanont,² Chakrarat Pittayawonganon,⁴ Chao-Tan Guo,⁷ Hiroaki Hiramatsu,⁷ Wipawee Jampangern,³ Supamit Chunsutthiwat,⁵ and Pilaipan Puthavathana¹

Faculty of Medicine, Siriraj Hospital,¹ Faculty of Science,² Faculty of Tropical Medicine,³ Mahidol University, Bangkok, Thailand; Bureau of Epidemiology,⁴ Department of Disease Control, Bangkok, Thailand,⁵ Faculty of Science, Kasetsart University, Bangkok, Thailand,⁶ College of Life and Health Sciences, Chubu University, Kasugai, Japan⁷

Received 5 March 2007/ Accepted 18 June 2007

Top ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

 
Avian influenza viruses preferentially recognize sialosugar chains terminating in sialic acid-2,3-galactose (SA2,3Gal), whereas human influenza viruses preferentially recognize SA2,6Gal. A conversion to SA2,6Gal specificity is believed to be one of the changes required for the introduction of new hemagglutinin (HA) subtypes to the human population, which can lead to pandemics. Avian influenza H5N1 virus is a major threat for the emergence of a pandemic virus. As of 12 June 2007, the virus has been reported in 45 countries, and 312 human cases with 190 deaths have been confirmed. We describe here substitutions at position 129 and 134 identified in a virus isolated from a fatal human case that could change the receptor-binding preference of HA of H5N1 virus from SA2,3Gal to both SA2,3Gal and SA2,6Gal. Molecular modeling demonstrated that the mutation may stabilize SA2,6Gal in its optimal cis conformation in the binding pocket. The mutation was found in approximately half of the viral sequences directly amplified from a respiratory specimen of the patient. Our data confirm the presence of H5N1 virus with the ability to bind to a human-type receptor in this patient and suggest the selection and expansion of the mutant with human-type receptor specificity in the human host environment.

Top ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

 
In contrast to most avian influenza viruses, which do not readily infect humans, highly pathogenic avian influenza H5N1 virus strains can transmit directly from avian species to humans and cause severe disease. Despite the ability to infect and cause severe disease in humans, most H5N1 viruses do not bind the sialic acid-2,6-galactose (SA2,6Gal) receptor with high affinity (17). It is believed that this receptor binding property is the major factor preventing the H5N1 virus from efficiently transmitting from person to person and causing a pandemic (17). The receptor binding preference of H5N1 viruses can be altered by only a few amino acid substitutions in the hemagglutinin (HA) protein. Mutations that change the receptor binding preference from the avian to the human type could potentially enable the virus to transmit efficiently in the human population and cause a catastrophic pandemic. Monitoring of the viral changes is therefore extremely important in the current situation where H5N1 viruses are spreading progressively.

A previous study showed that mutations at positions 226 and 228 (H3 numbering) (Q226L and G228S), which are the adaptive mutations for H2 and H3 (5, 19), could reduce the binding affinity to sialic acid-2,3-galactose (SA2,3Gal) of an H5N1 virus isolated in 1997 (5, 19). Human H5N1 isolates from Hong Kong that were isolated in 2003, which contain a mutation at position 227 (S227N) (H3 numbering), were shown to have a reduced binding affinity toward SA2,3Gal and an increased affinity toward SA2,6Gal (1). Another report demonstrated previously that neither these mutations nor the mutations that could adapt H1 viruses to the human receptor (E190D and G225D) (H3 numbering) could completely convert a Vietnam H5N1 virus isolated in 2004 to the 2,6-type receptor specificity (16). Except for S227N, these mutations have not been found in H5N1 viruses isolated from humans or animals. Recently, N182K and Q192R mutations were shown to enhance the binding of a Vietnam H5N1 HA isolated in 2004 to the SA2,6Gal receptor (20). Although it was described previously that the N182K mutation was found in Kan-1 HA (20), the original Kan-1 virus as well as the HA sequence of Kan-1 in the GenBank Database do not contain this mutation. It is not clear from where this mutation was derived. The Q192R mutation was found in a clone that was present as a minor population in a viral isolate and was identified after plaque purification. In contrast, here, we show a naturally occurring mutant with an ability to bind SA2,6Gal that was directly identified in a human nasopharyngeal specimen.

Top ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

 
Cloning and generation of mutants. A fragment of the HA gene covering the receptor binding site (nucleotides 413 to 905) was amplified from RNA extracted from the nasopharyngeal specimen using the high-fidelity enzyme Pfu and primers HHAf2 (GGTCCAGTCATGAAGCCTCA) and HA-H5r12 (TTTATCGCCCCCATTGGAGT). The PCR product was cloned into pGEM-T Easy. One hundred clones were picked up and sequenced. Two clones were pooled for each sequencing reaction. A clone with L129V and A134V mutations was used in a spliced overlapping extension reaction, which joined two PCR fragments with overlapping sequences. The reaction swapped the sequence with the mutations into the HA gene of Kan-1 virus in the reverse genetic plasmid pHw2000, in which the cleavage site had been modified to a low-pathogenic sequence. Wild-type or the mutant pHw2000 HA was transfected into Vero cells together with the other seven genomic segments of A/Puerto Rico/8/34 (H1N1) to generate the viruses.

Hemagglutination assay. A 10% suspension of goose (Anser cygnoides) red blood cells was prepared in phosphate-buffered saline (PBS), and a 50-µl aliquot was treated with 1.25 U of 2,3-sialidase cloned from Salmonella enterica serovar Typhimurium LT2 (7) (Takara, Japan) for 1 h at 37°C. Untreated and treated red blood cells were used in the hemagglutination assay.

HA-receptor binding assay. The receptor binding preference was analyzed by a solid-phase direct binding assay as previously described (20) by using the sialylglycopolymer, which contains N-acetylneuraminic acid linked to galactose through either an 2,3 or an 2,6 bond (Neu5Ac2, 3LacNAcb-pAP, and Neu5Ac2,6LacNAcb-pAP) (18). Serial dilutions of each sialylglycopolymer were prepared in PBS, and 100 µl was added to the wells of 96-well microtiter plates (Polystyrene Universal-Bind Microplate; Corning) and allowed to attach overnight at 4°C. The plate containing sialylglycopolymer was irradiated under UV light at 254 nm for 10 min and then washed five times with 200 µl PBS. The plate was blocked for 8 h at 4°C with PBS containing 2% skim milk powder. After washing five times with 200 µl PBS containing 0.1% Tween 20, virus culture supernatant containing 128 HA units was allowed to attach onto the plate on ice overnight. After the incubation, the plate was washed five times with ice-cold PBS-0.1% Tween 20, and 50 µl of anti-HA goat hyperimmune serum at a dilution of 1:2,000 was added to each well and was allowed to incubate on ice for 2 h. The plate was then washed again with ice-cold PBS-0.1% Tween 20, and 50 µl of the polyclonal rabbit anti-goat immunoglobulin-horseradish peroxidase conjugate (DakoCytomation) at a dilution of 1:2,000 was added to each well. After incubation on ice for 2 h, the wells were extensively washed with PBS-0.1% Tween 20, and 100 µl per well of premixed tetramethylbenzidine-H₂O₂ substrate was added. After incubation at room temperature for 15 min, the reaction was stopped with 50 µl of 1 M H₂SO₄, and the absorbance at 450/630 nm was read.

Molecular dynamic simulation. The crystal structures of HA from A/Duck/Singapore/3/97 (H5N1) (4) were used as templates for the simulations of HA binding to SA2,3Gal (Protein Data Bank [PDB] accession number 1JSN) and SA2,6Gal (PDB accession number 1JSO). In the structural template under PDB accession number 1JSO, the sialic residue has no galactose unit connected; therefore, we added it with the torsion angle of 55°. Both glycosides in the two structures were terminated with a methoxy group and used as the input for molecular dynamic simulations. In homology modeling, the wild-type and mutant HA (L129V/A134V) were three-dimensionally aligned via the SWISS-MODEL server (12) using PDB accession numbers 1JSN and 1JSO and used as the initial input structures for molecular dynamic simulations. In order to provide a control of classical SA2,6Gal-tropic HA, we ran a human influenza virus H1 HA structure (PDB accession number 1RVZ) (2) in a similar simulation.

All structures were solvated using the TIP5P water model (10), and we performed energy minimization to relieve bad contacts caused by unreasonable distances in the initial structures and then equilibrated for 100 ps before a 3-ns productive run at 300K using the SANDER module in the AMBER9 program (University of California, San Francisco) with a Glycam04 parameter (http://glycam.ccrc.uga.edu). Xmgrace (http://plasma-gate.weizmann.ac.il/Grace/), VMD (8), and AMBER tools running on UNIX were exploited to visualize and manipulate all figures.

Top ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

 
We screened for H5N1 isolates with altered receptor-binding preferences by a hemagglutination assay using goose red blood cells that were treated with a SA2,3Gal-specific sialidase (7). Theoretically, the sialidase digestion should abolish hemagglutination by SA2,3Gal-specific viruses, whereas viruses that can bind to SA2,6Gal should maintain hemagglutination activity with the treated red blood cells. The sialidase treatment did not affect the hemagglutination titer of human influenza viruses. An example of H1N1 virus (A/Thailand/Siriraj-12/06), the hemagglutination titer of which was not affected by the treatment, is shown in Fig. 1a. We have tested four human H5N1 isolates [A/Thailand/1(KAN-1)/2004, A/Thailand/3(SP-83)/2004, A/Thailand/5(KK-494)/2004, and A/Thailand/676/2005]. The sialidase treatment completely abolished the hemagglutination activity of all the viruses with more than a 256-fold reduction in the hemagglutination titer except for A/Thailand/676/2005 (Th676), which partially maintained its hemagglutination activity in sialidase-treated red blood cells with some reduction in the hemagglutination titer (Fig. 1a). This suggested an enhanced binding of this virus to SA2,6Gal. The virus was isolated from a 5-year-old boy in Thailand. The patient had a progressive viral pneumonia that led to respiratory failure and death by 12 days after onset of illness.

View larger version (31K): [in this window] [in a new window]

FIG. 1. (a) Abolition of hemagglutination titers in SA2,3Gal-specific sialidase-treated red blood cells compared to those in untreated cells indicated SA2,3Gal monospecificity for H5N1 viruses except for Th676 and the L129V/A134V reverse genetic virus, the titers of which were only modestly affected, suggesting an enhanced binding to SA2,6Gal. (b) Electropherogram of sequencing reaction of the Th676 virus shows a T-to-G mutation changing the amino acid from leucine to valine at position 129 and a C-to-T mutation changing the amino acid from alanine to valine at position 134 (arrowheads).

Sequence of the HA gene of Th676 (GenBank accession number DQ360835) revealed two substitutions at position 129 (leucine to valine [L129V]) and position 134 (alanine to valine [A134V]). These two substitutions were particularly interesting because they are located close to the 130 loop of the receptor binding domain (14). Direct sequencing of viral RNA from culture showed double peaks at both positions, indicating a mixture of wild-type and mutant viruses. The mutant peaks at both positions were two- to threefold higher than the wild-type peaks (Fig. 1b). We have also amplified the viral sequence directly from a nasopharyngeal specimen. Cloning and sequencing of the amplification products showed the substitution L129V in 54 out of 92 clones and the substitution A134V in 52 out of 92 clones. Among these mutant clones, 42 had both substitutions (45.6% of total clones). In order to test whether these two substitutions were responsible for the alteration of receptor binding preference, we generated reverse genetic viruses with wild-type HA or mutated HA carrying these two substitutions individually or simultaneously by the reverse genetics method (6). However, the mutated HA carrying A134V alone did not yield viable virus, probably because the mutation was not compatible with the genetic background of the reverse genetic virus. The wild-type HA clone was derived from A/Thailand/1(KAN-1)/2004 (H5N1) (Kan-1). Other genomic segments of the reverse genetic viruses were obtained from A/PR/8/34 (H1N1). In contrast to the Kan-1 HA described recently by Yamada et al. to bind SA2,6Gal (20), our Kan-1 HA clone (GenBank accession number EF107522) as well as the Kan-1 viral isolate (GenBank accession number AY555150) do not contain the N182K mutation, which was described to enhance binding to SA2,6Gal (20). The hemagglutination pattern of the L129V/A134V reverse genetic virus indicated an enhanced SA2,6Gal binding, whereas that of the L129V virus did not (Fig. 1a). The lesser degree of reduction of the hemagglutination titer of the L129V/A134V reverse genetic virus (fourfold) compared to that of Th676 (eightfold) might reflect the fact that Th676 was a mixture of wild-type and mutant viruses. We also used a recently described direct binding assay using sialylglycopolymers (3) and confirmed the effect of the L129V/A134V mutation on the receptor binding preference. The reverse genetic virus carrying wild-type Kan-1 HA showed SA2,3Gal specificity and did not bind significantly to SA2,6Gal, whereas a human H1N1 virus, A/Thailand/Siriraj-12/06, bound only to SA2,6Gal (Fig. 2a and b). Also, while the L129V mutation alone did not change the receptor binding preference, the HA containing both L129V and A134V mutations bound equally well to both SA2,3Gal and SA2,6Gal (Fig. 2c and d).

View larger version (26K): [in this window] [in a new window]

FIG. 2. Direct binding assay using sialylglycopolymers. Human H1N1 virus (A/Thailand/Siriraj-12/06) showed receptor preference for SA2,6Gal (a), whereas the reverse genetic virus with Kan-1 wild-type HA showed receptor preference for SA2,3Gal (b). The reverse genetic virus carrying HA with the L129V mutation showed a receptor preference similar to that of the wild-type virus (c), whereas the virus carrying HA with L129V/A134V mutations showed receptor preference for both SA2,3Gal and SA2,6Gal (d). Diamonds represent absorbencies of SA2,3Gal binding, and squares represent absorbencies of SA2,6Gal binding.

In the HA binding pocket, the SA2,3Gal and SA2,6Gal receptors were shown to have a specific conformation, either cis or trans (4). Torsion angle () is the angle between two planes containing O6, C1 of the SA unit, and O3 (or O6), C3 of Gal unit (Fig. 3a). The angle indicates whether the glycoside is in the cis ( = 56°) or trans ( = –55°) conformation (Fig. 3a). Within its bound state to H5 in an X-ray cocrystal structure (4), SA2,3Gal was found in the trans conformation. The trans conformation of SA2,3Gal allows 4-OH (O4) and the glycosidic oxygen (O3) of the Gal unit to interact optimally with Gln222 of H5 (4). In contrast, if bound in the trans conformation, the 4-OH in SA2,6Gal would be too far away from Gln222, and if bound in the cis conformation, the glycosidic oxygen (O6) in SA2,6Gal would be too far away from Gln222. The lack of interactions between 4-OH and Gln222 in the trans conformation and between O6 and Gln222 in the cis conformation makes the binding of H5 to SA2,6Gal unstable in both conformations. The conformation of SA2,6Gal in solution was shown to have a cis-to-trans ratio of 9:1 (11), which suggests that the optimal binding conformation for SA2,6Gal is cis because no additional energy would be required for the conformational change. Furthermore, recent molecular modeling has predicted SA2,6Gal in H5 binding to be in the cis conformation (9). In our simulation, human H1 (PDB accession number 1RVZ) showed an average SA2,6Gal angle of 63°, which indicated a cis conformation (Fig. 3b). This provides a positive control for SA2,6Gal binding in our simulation and indicates that the angle can be used as an indicator of the receptor preference. In order to have structural insight into the altered receptor specificity of the mutant HA, we performed molecular dynamic simulations using two sialic acid-H5 cocrystals as reference structures for the two types of glycosidic linkages, SA2,3Gal (PDB accession number 1JSN) and SA2,6Gal (PDB accession number 1JSO) (4). In our modeling, both the wild-type and the mutant L129V/A134V HAs shared similar binding patterns within the sialic binding pocket as previously reported for both SA2,3Gal and SA2,6Gal binding (14, 19). However, it was observed that over the period of simulations, hydrophobicity and spatial constraint changes at residues 129 and 134 due to the different alkyl side chains, especially the A134V mutation, which happened near the glycosidic linkage, caused some changes in glycoside binding patterns. The angle indicated that SA2,6Gal in the L129V/A134V HA spent most of the time in the low-energy cis conformation, whereas those in the wild-type Kan-1 HA and the template H5 were forced to change from their cis conformation in the initial input structures to the trans conformation (Fig. 3c). Although SA2,6Gal in both wild-type Kan-1 HA and the template HA was in the trans conformation at the end of the simulation period, SA2,6Gal in Kan-1 HA stayed longer in the cis conformation than that in the template HA. This suggested that wild-type Kan-1 HA might have a slightly increased affinity for SA2,6Gal compared to the template HA of A/Duck/Singapore/3/97. The increased stability in the cis conformation of the binding to L129V/A134V HA was due to an alternative interaction between Gly221 and 4-OH or 3-OH (O3) of Gal caused by a displacement of Gly221 by the A134V mutation (Fig. 3d). In the simulations of SA2,3Gal binding to L129V/A134V HA, the angle significantly moved away from the preferred angle (from –55° to –30°) (Fig. 3c). Although SA2,3Gal was still in the trans conformation, the A134V mutation pushed Gln222 slightly away from the optimal binding condition. The widening of the gap between Gln222 and the glycosidic oxygen (O3) caused by larger hydrophobic side chain of Val134 might reduce the binding affinity of the mutant HA for SA2,3Gal.

View larger version (44K): [in this window] [in a new window]

FIG. 3. The two glycoside backbone conformations, SA2,6Gal and SA2,3Gal, cut from the X-ray cocrystals under PDB accession numbers 1JSI and 1JSIN (4) with different values for torsion () angles that were used as the cis or trans conformation characteristics (a). For a human H1 virus (PDB accession number 1RVZ), SA2,6Gal showed an average angle of 63°, indicating a cis conformation in the molecular dynamic simulation (b). The amount of time that each receptor analog spent having a particular angle for SA2,3Gal (top) and SA2,6Gal (bottom) in the binding sites of the template H5 (A/Duck/Singapore/3/97) (black), wild-type Kan-1 (green), and the L129V/A134V mutant (red) as the results of molecular dynamics simulations indicated an altered binding conformation in the L129V/A134V mutant (c). The modeling showed that SA2,6Gal in a cis conformation in the wild-type Kan-1 HA pockets had long distances between O6 and Gln222 (3.47 Å) and between 4-OH and Gly221 (7.72 Å) (left). However, in the L129V/A134V mutant, the glycoside was stabilized with the Gly221 and Gal interactions as observed by the shorter distance between 4-OH and Gln221 (2.02 Å) (right) (d).

Top ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

 
In humans, the SA2,6Gal receptor is expressed mainly in the upper airway, while the SA2,3Gal receptor is expressed in alveoli and the terminal bronchiole (13). A virus with good affinity to both SA2,3Gal and SA2,6Gal receptors may be a very dangerous one, which could both infect efficiently via its binding to SA2,6Gal in the upper airway and cause severe infection in the lung via its binding to SA2,3Gal. This hypothesis is supported by the fact that one of the two well-characterized HA genes from the H1N1 1918 pandemic virus binds efficiently to both SA2,3Gal and SA2,6Gal (3, 15).

Although receptor binding preference is a major factor determining host species tropism, we do not know whether the alteration in receptor binding properties is sufficient to enable the virus to transmit from person to person efficiently. Nevertheless, our finding indicated that an adaptation of H5N1 virus to the human host by receptor binding site modification could and did indeed happen. Since the identification of this patient, there have been three confirmed human cases in the country, but none of the viral isolates from these cases contained the L129V and A134V substitutions. It is likely that this particular mutant has been eliminated by infection control measures.

Our report demonstrates that avian influenza H5N1 virus could be naturally adapted to the human-type receptor. We need to intensify our effort to detect such viruses as early as possible. Our data also provide a genetic marker that can be used to screen for an H5N1 virus with pandemic potential. H5N1 viruses may have several ways to adapt their receptor binding properties, but mutations that were found directly in patients, such as L129V/A134V, are more likely than those artificially generated and tested mutations to be the mutation that could cause a pandemic.

 
This work was supported by a research grant from the National Research Council, the Ellison Foundation, and the National Center for Genetic Engineering and Biotechnology of Thailand. All molecular modeling was conducted on the PSIPHI computer cluster at the National Center for Genetic Engineering and Biotechnology (BIOTEC) and financially supported by Thailand Research Fund (TRF) and Kasetsart University Research and Development Institute (KURDI).

We thank Atthapon Eiamudomkan, Prasongsak Nakhornkwang, Manee Phonpasee, Sanya Kittisoontaropas, Vivat Pvongpasert, Wannasatre Rattanalum, Chansuda Sukbumrung, and Sompong Boonsuepchat of the NakhonNayok Provincial Public Health Office. The reverse genetic plasmid pHw2000 with A/PR/8/34 genomic segments was kindly provided by R. G. Webster and E. Hoffmann. The activity was a part of the newly established Thailand Avian Influenza Monitoring Network (TAIM Net).

 
* Corresponding author. Mailing address: Department of Microbiology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand. Phone: 662 4197068. Fax: 662 4184148. E-mail: sipaw{at}mahidol.ac.th

Published ahead of print on 11 July 2007.

Top ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

 

1
1. Gambaryan, A., A. Tuzikov, G. Pazynina, N. Bovin, A. Balish, and A. Klimov. 2006. Evolution of the receptor binding phenotype of influenza A (H5) viruses. Virology 344:432-438.[CrossRef][Medline]
2
2. Gamblin, S. J., L. F. Haire, R. J. Russell, D. J. Stevens, B. Xiao, Y. Ha, N. Vasisht, D. A. Steinhauer, R. S. Daniels, A. Elliot, D. C. Wiley, and J. J. Skehel. 2004. The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science 303:1838-1842.[Abstract/Free Full Text]
3
3. Glaser, L., J. Stevens, D. Zamarin, I. A. Wilson, A. Garcia-Sastre, T. M. Tumpey, C. F. Basler, J. K. Taubenberger, and P. Palese. 2005. A single amino acid substitution in 1918 influenza virus hemagglutinin changes receptor binding specificity. J. Virol. 79:11533-11536.[Abstract/Free Full Text]
4
4. Ha, Y., D. J. Stevens, J. J. Skehel, and D. C. Wiley. 2001. X-ray structures of H5 avian and H9 swine influenza virus hemagglutinins bound to avian and human receptor analogs. Proc. Natl. Acad. Sci. USA 98:11181-11186.[Abstract/Free Full Text]
5
5. Harvey, R., A. C. Martin, M. Zambon, and W. S. Barclay. 2004. Restrictions to the adaptation of influenza a virus H5 hemagglutinin to the human host. J. Virol. 78:502-507.[Abstract/Free Full Text]
6
6. Hoffmann, E., G. Neumann, Y. Kawaoka, G. Hobom, and R. G. Webster. 2000. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc. Natl. Acad. Sci. USA 97:6108-6113.[Abstract/Free Full Text]
7
7. Hoyer, L. L., P. Roggentin, R. Schauer, and E. R. Vimr. 1991. Purification and properties of cloned Salmonella typhimurium LT2 sialidase with virus-typical kinetic preference for sialyl alpha 2-3 linkages. J. Biochem. (Tokyo) 110:462-467.[Abstract/Free Full Text]
8
8. Humphrey, W., A. Dalke, and K. Schulten. 1996. VMD: visual molecular dynamics. J. Mol. Graph. 14:27-28, 33-38.
9
9. Li, M., and B. Wang. 2006. Computational studies of H5N1 hemagglutinin binding with SA-alpha-2,3-Gal and SA-alpha-2,6-Gal. Biochem. Biophys. Res. Commun. 347:662-668.[CrossRef][Medline]
10
10. Mahoney, M. W., and W. L. Jorgensen. 2000. A five-site model for liquid water and the reproduction of the density anomaly by rigid, nonpolarizable potential functions. J. Chem. Physics 112:8910-8922.[CrossRef]
11
11. Poppe, L., R. Stuike-Prill, B. Meyer, and H. van Halbeek. 1992. The solution conformation of sialyl-alpha (2-6)-lactose studied by modern NMR techniques and Monte Carlo simulations. J. Biomol. NMR 2:109-136.[CrossRef][Medline]
12
12. Schwede, T., J. Kopp, N. Guex, and M. C. Peitsch. 2003. SWISS-MODEL: an automated protein homology-modeling server. Nucleic Acids Res. 31:3381-3385.[Abstract/Free Full Text]
13
13. Shinya, K., M. Ebina, S. Yamada, M. Ono, N. Kasai, and Y. Kawaoka. 2006. Avian flu: influenza virus receptors in the human airway. Nature 440:435-436.[CrossRef][Medline]
14
14. Skehel, J. J., and D. C. Wiley. 2000. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 69:531-569.[CrossRef][Medline]
15
15. Stevens, J., O. Blixt, L. Glaser, J. K. Taubenberger, P. Palese, J. C. Paulson, and I. A. Wilson. 2006. Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. J. Mol. Biol. 355:1143-1155.[CrossRef][Medline]
16
16. Stevens, J., O. Blixt, T. M. Tumpey, J. K. Taubenberger, J. C. Paulson, and I. A. Wilson. 2006. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 312:404-410.[Abstract/Free Full Text]
17
17. Suzuki, Y. 2005. Sialobiology of influenza: molecular mechanism of host range variation of influenza viruses. Biol. Pharm. Bull. 28:399-408.[CrossRef][Medline]
18
18. Totani, K., T. Kubota, T. Kuroda, T. Murata, K. I. Hidari, T. Suzuki, Y. Suzuki, K. Kobayashi, H. Ashida, K. Yamamoto, and T. Usui. 2003. Chemoenzymatic synthesis and application of glycopolymers containing multivalent sialyloligosaccharides with a poly(L-glutamic acid) backbone for inhibition of infection by influenza viruses. Glycobiology 13:315-326.[Abstract/Free Full Text]
19
19. Vines, A., K. Wells, M. Matrosovich, M. R. Castrucci, T. Ito, and Y. Kawaoka. 1998. The role of influenza A virus hemagglutinin residues 226 and 228 in receptor specificity and host range restriction. J. Virol. 72:7626-7631.[Abstract/Free Full Text]
20
20. Yamada, S., Y. Suzuki, T. Suzuki, M. Q. Le, C. A. Nidom, Y. Sakai-Tagawa, Y. Muramoto, M. Ito, M. Kiso, T. Horimoto, K. Shinya, T. Sawada, T. Usui, T. Murata, Y. Lin, A. Hay, L. F. Haire, D. J. Stevens, R. J. Russell, S. J. Gamblin, J. J. Skehel, and Y. Kawaoka. 2006. Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature 444:378-382.[CrossRef][Medline]

---

Journal of Virology, September 2007, p. 9950-9955, Vol. 81, No. 18
0022-538X/07/$08.00+0     doi:10.1128/JVI.00468-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

This article has been cited by other articles:

• Kitphati, R., Pooruk, P., Lerdsamran, H., Poosuwan, S., Louisirirotchanakul, S., Auewarakul, P., Chokphaibulkit, K., Noisumdaeng, P., Sawanpanyalert, P., Puthavathana, P. (2009). Kinetics and Longevity of Antibody Response to Influenza A H5N1 Virus Infection in Humans. CVI 16: 978-981 [Abstract] [Full Text]  
• Chaichoune, K., Wiriyarat, W., Thitithanyanont, A., Phonarknguen, R., Sariya, L., Suwanpakdee, S., Noimor, T., Chatsurachai, S., Suriyaphol, P., Ungchusak, K., Ratanakorn, P., Webster, R. G., Thompson, M., Auewarakul, P., Puthavathana, P. (2009). Indigenous sources of 2007-2008 H5N1 avian influenza outbreaks in Thailand. J. Gen. Virol. 90: 216-222 [Abstract] [Full Text]  
• Keleta, L., Ibricevic, A., Bovin, N. V., Brody, S. L., Brown, E. G. (2008). Experimental Evolution of Human Influenza Virus H3 Hemagglutinin in the Mouse Lung Identifies Adaptive Regions in HA1 and HA2. J. Virol. 82: 11599-11608 [Abstract] [Full Text]  
• Kongchanagul, A., Suptawiwat, O., Kanrai, P., Uiprasertkul, M., Puthavathana, P., Auewarakul, P. (2008). Positive selection at the receptor-binding site of haemagglutinin H5 in viral sequences derived from human tissues. J. Gen. Virol. 89: 1805-1810 [Abstract] [Full Text]  
• Watanabe, T., Watanabe, S., Kim, J. H., Hatta, M., Kawaoka, Y. (2008). Novel Approach to the Development of Effective H5N1 Influenza A Virus Vaccines: Use of M2 Cytoplasmic Tail Mutants. J. Virol. 82: 2486-2492 [Abstract] [Full Text]  
• Wang, Q., Tian, X., Chen, X., Ma, J. (2007). Structural basis for receptor specificity of influenza B virus hemagglutinin. Proc. Natl. Acad. Sci. USA 104: 16874-16879 [Abstract] [Full Text]  

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Auewarakul, P. Articles by Puthavathana, P. Search for Related Content PubMed PubMed Citation Articles by Auewarakul, P. Articles by Puthavathana, P.